Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis

Lancet

Volumn 351, Issue SUPPL.3, 1998, Pages 5-7

  Cohen, Myron S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; VIRUS TRANSMISSION;

EID: 0002724443     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(98)90002-2     Document Type: Article

References (43)

1. Royce RA., Seña A, Cates W, Cohen M. Sexual transmission of HIV-1. N Engl J Med 1997; 336: 1072-78.
2. Vernazza PL, Gilliam B, Dyer JR, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997; 11989-95.
3. Combs RW, Speck CE, Hughes JF, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998; 177: 320-330.
4. Xu C, Politch JA, Tucker L, Mayer KH, Seage GR III, Anderson DJ. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis 1997; 176: 941-47.
5. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997; 11: F85-93.
6. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350: 922-27.
7. Dyer J, Gilliam B, Eron JJ, Cohen MS, Fiscus S, Vernazza P. Shedding of HIV in semen during primary infection. AIDS 1997; 11: 543-45.
8. Musicco M, Lazzarin A, Nicolosi A, et al. Antiretrovtral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med 1994; 154: 1971-76.
9. Operskalski EA, Stram DO, Busch MP, et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Am J Epidemiol 1997; 146: 655-61.
10. Fiore JR, Zhang Y, Bjorndal A, et al. Biological correlates of HIV-1 heterosexual transmission. AIDS 1997; 11: 1089-94.
11. Graziosi C, Pantaleo G. The multi-faceted personality of HIV. Nature 1997; 3: 1318-20.
12. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to ATDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856-62.
13. Zaitseva A. Blauvelt A, Lee S, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature 1997; 3: 1369-75.
14. Poss M, Martin HL, Kreiss JK, et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Viral 1995; 69: 8118-22.
15. van't Wout AB, Kootstra NA, Mulder-Kampinga GA, et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest 1994; 94: 2060-67.
16. Kunanusont C, Foy HM, Kreiss JK, et al. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 1995; 345: 1078-83.
17. Soto-Ramirez LE, Renjifo B, McLane MF, et al. HIV-1 Langerhans cell tropism associated with heterosexual transmission of HIV. Science 1996; 271: 1291-93.
18. Pope M, Ho DD, Moore JP, Weber J, Dittmar MT, Weiss RA. Different subtypes of HIV-1 and cutaneous dendritic cells. Science 1997; 278: 786-87.
19. Mazzaoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature 1997; 3: 1250-57.
20. Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996; 17: 21-24.
21. Wasscrhcit JN. Epidcmiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
22. Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill criteria. Sex Transm Dis 1996; 23: 429-40.
23. Ho JL, He S, Hu A, et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HTV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1997; 181: 1493-505.
24. Theus SA, Harrich DA, Gavnor R, Radolf D, Noreard MV. Treponema pallidum lipoproteins and synthetic lipoprotein anaiogues induce human immunodeficiency virus type 1 gene expe monocytes via NF-kB activation. In: J Infect Dis 1998; 177: 941-950.
25. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99: 77-87.
26. Eron JJ, Gilliam B, Fiscus S, Dyer J, Cohen MS. HIV-1 shedding and chlamydial urethritis. JAMA 1996; 275: 36.
27. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4.cell depletion. J Infect Dis 1995; 172: 1469-74.
28. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-I in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349: 1868-73.
29. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis 1998; 177: 224-27.
30. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175: 57-62.
31. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177: 167-74.
32. Spear GT, Al-Harthi L, Sha B, et al. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1 infected and uninfected women. AIDS 1997; 11: 1319-26.
33. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-36.
34. Mayaud P, Mosha F, Todd J, et al. Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial. AIDS 1997; 11: 1873-80.
35. Wawer MJ, Gray RH, Quinn T. AIDS intervention in Uganda. Science 1995; 270: 564-65.
36. The World Bank (USA). Confronting AIDS: public priorities in a global epidemic. New York: Oxford University Press; 1997.
37. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997; 350: 1805-09.
38. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350: 546-50.
39. Taha TE, Liomba G, Kumwenda N, et al. Association of bacterial vaginosis with HIV, preterm delivery and perinatal HIV infection [abstr B172], Xth International Conference on AIDS and STD; 1997: Abidjan, Ivory Coast.
40. Cohen MS, Dallabetta G, Laga M, Holmes KK. A new deal in HIV prevention: lessons from the global approach. Ann Intern Med 1994; 120: 340-41.
41. Quinn TC, Glasser D, Cannon RO, et al. Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988; 318: 197-203.
42. Catchpole MA, Mercey DE, Nicoll A, et al. Continuing transmission of sexually transmitted diseases among patients infected with HIV-1 attending genitourinary medicine clinics in England and Wales. BMJ 1996; 312: 539-42.
43. Bersoff-Matcha SI, Horgan MM, Stoner BP, Mundy LM, Fraser VJ. Sexually transmitted disease acquisition among HIV-infected women [abstr 546]. In: Infectious Disease Society of America 35th Annual Meeting (1997).